Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

The resources are part of a nationwide collaboration between Lilly and the American Diabetes Association to destigmatize obesity and encourage stigma-free obesity care. “It’s time to recognize obesity ...

Those at risk include people living with type 2 diabetes or high blood pr Eli Lilly and Company (NYSE: LLY) today announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing ...

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity therapies – but still said sales rose around a third over the prior year.

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

Glucose tracking isn’t just for diabetics anymore When you think of glucose monitors, you probably picture something only diabetics use. Which is true as for many years, continuous glucose ...

The Precision Xtra Blood Glucose & Ketone Monitoring System was designed for easy testing. Intuitive setup and simple icon-driven menus help simplify blood glucose monitoring. In addition ...

a blood glucose monitoring device with the tools and a support system to put in control of the diabetes and not the other way around. Checking the blood glucose with the BGStarTM couldn’t be ...

How saving with HL works How to build your emergency cash savings How much cash should you hold? View all savings insights ...

The American Heart Association recommends that anyone with high blood pressure (typically 130/80 mmHg or higher) should monitor their blood pressure at home. Regular monitoring helps your doctor ...

After hours: 8:00:00 p.m. EST Loading Chart for LLY ...